← Leaderboards
Lizhong Wang
University Of Alabama At Birmingham
$2,698,472
Attributed
$4,650,762
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $810.9K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,650,762 · 7
By mechanism
R01$2,588,541 · 2
R21$1,452,714 · 4
U54$609,507 · 1
Top collaborators
- Runhua Runa Liu5 shared
- Xiaoguang Margaret Liu5 shared
- Kai Jiao4 shared
- Qin Wang1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Runhua Runa Liu$2,517,658
- Xiaoguang Margaret Liu$3,757,363
- Edward E Partridge$43,798,134
- Michael S. Saag$146,765,034
- Isabel C Scarinci$19,061,797
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMouse ModelSamplingTumor StageBioinformaticsOverexpressionIn VivoCessation Of LifeTissuesData SetXenograft ProcedureBreast Cancer CellErbb2 GeneDiagnosisMalignant Breast NeoplasmAfrican AmericanAmericanCellsBreast Cancer PatientGeneticCancer EtiologyRaceNeoplasm MetastasisIn Vitro
Grant awards (17)
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction$442,613
R01 · FY2024 · CA · contact PI
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women$322,710
R01 · FY2024 · CA
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction$478,030
R01 · FY2023 · CA · contact PI
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women$332,900
R01 · FY2023 · CA
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women$332,900
R01 · FY2022 · CA
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women$339,694
R01 · FY2021 · CA
Establish Mouse Models to Evaluate Androgen Deprivation Therapy on AD$408,375
R21 · FY2020 · AG · contact PI
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women$339,694
R01 · FY2020 · CA
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$203,169
U54 · FY2018 · CA · contact PI
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$203,169
U54 · FY2017 · CA · contact PI
Project 1: CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$203,169
U54 · FY2016 · CA · contact PI
Roles of Semaphorin Signaling in Breast Cancer Racial Disparities$159,863
R21 · FY2016 · CA
Roles of Semaphorin Signaling in Breast Cancer Racial Disparities$191,835
R21 · FY2015 · CA
MicroRNAs for monitoring tumor progression and predicting response to therapy$159,863
R21 · FY2015 · CA · contact PI
MicroRNAs for monitoring tumor progression and predicting response to therapy$191,835
R21 · FY2014 · CA · contact PI
FOXP3-microRNA146-NFkB Axis in Tumor Suppression$149,760
R21 · FY2013 · CA · contact PI
FOXP3-microRNA146-NFkB Axis in Tumor Suppression$191,183
R21 · FY2012 · CA · contact PI